×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OKUR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
08:38 am
okur
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Ka Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies [Yahoo! Finance]
Low
Report
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Ka Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies [Yahoo! Finance]
3/27
08:00 am
okur
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Ka Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
High
Report
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Ka Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
3/16
08:03 am
okur
OnKure Therapeutics (OKUR) had its price target lowered by HC Wainwright from $34.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
OnKure Therapeutics (OKUR) had its price target lowered by HC Wainwright from $34.00 to $27.00. They now have a "buy" rating on the stock.
3/14
01:32 am
okur
OnKure Therapeutics (OKUR) was upgraded by Wall Street Zen from "sell
Low
Report
OnKure Therapeutics (OKUR) was upgraded by Wall Street Zen from "sell
3/12
04:05 pm
okur
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/24
06:58 pm
okur
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Saccomano Nicholas A
Low
Report
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Saccomano Nicholas A
3/24
06:56 pm
okur
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Leverone Jason A.
Low
Report
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Leverone Jason A.
3/12
04:11 pm
okur
Form 10-K OnKure Therapeutics, For: Dec 31
Medium
Report
Form 10-K OnKure Therapeutics, For: Dec 31
3/12
04:06 pm
okur
Form 8-K OnKure Therapeutics, For: Mar 12
Medium
Report
Form 8-K OnKure Therapeutics, For: Mar 12
2/17
08:15 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
2/17
04:54 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
2/17
04:12 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: